Dr. Mecker Moller
Dr. Mecker Moller is a surgical oncologist and professor of surgery at the University of Chicago. While at the University of Miami she performed South Florida’s first cytoreduction and hyperthermic intraperitoneal chemotherapy combination procedure.
- Surgical Oncologist
- Peritoneal Specialist
- Expertise:
-
Cytoreductive Surgery
HIPEC - Speciality:
-
Surgical Oncology
- Gender:
-
Female
- Language:
-
English, Spanish
Primary Location
- Other Doctors At This Location
-
Dr. Mark FergusonThoracic Surgeon
Dr. Alexandra FunakiRadiologist
Dr. Renuka MalikRadiation Oncologist
Dr. Hedy Lee KindlerOncologist
Dr. Jessica DoningtonThoracic Surgeon
Free Mesothelioma Treatment Guide
- Expertise:
-
Cytoreductive Surgery
HIPEC - Speciality:
-
Surgical Oncology
- Gender:
-
Female
- Language:
-
English, Spanish
Get to Know Dr. Mecker Moller
Dr. Mecker Moller has experience in treating many types of abdominal malignancies, including peritoneal mesothelioma, which is caused by an exposure to asbestos fibers.
Dr. Moller is the director of the Regional Therapies (HIPEC) Program and the Surgical Oncology Fellowship Program at the University of Chicago.
She has played a major role in mesothelioma treatment advances by mastering the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
HIPEC involves circulating a heated, high-dose chemotherapy solution throughout the abdominal cavity for up to 90 minutes immediately following the surgery.
The intent is to kill any microscopic tumor cells that evaded the surgeon. Keeping chemotherapy drugs in the abdominal cavity, then draining them in the operating room, allows doctors to use higher-than-normal dosage levels without causing serious side effects.
Moller has used the procedure successfully for colon, pancreas, gastrointestinal tract and ovarian cancers, along with several other types.
Specialties of Dr. Mecker Moller
- Peritoneal mesothelioma
- Colon cancer
- Ovarian cancer
- Appendiceal cancer
- Gastrointestinal disease
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Cytoreductive surgery
Dr. Mecker Moller’s Experience and Medical Education
- University of Chicago Comprehensive Cancer Center
- University of Miami Sylvester Comprehensive Cancer Center
- University of Miami School of Medicine (Associate professor of surgery)
- Universidad Nacional Autonoma De Nicaragua, Leon (M.D.)
- Moffitt Cancer Center/University of South Florida (Fellowship)
- Michigan State University Grand Rapids Medical Education and Research Center (Residency)
Awards and Other Recognitions
- Peritoneal Surface Malignancy Program (Leader)
- American Chemical Society (Fellows program)
- American Board of Surgery
- Top Doctors
Publications of Dr. Mecker Moller
- Moller, M.G. et al. (2009). Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Annals of Surgical Oncology.
- Moller, M.G. et al. (2008). Mentoring the modern surgeon. Bulletin of the American College of Surgeons.
- Moller, M.G. et al. (2008). Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. International Journal of Hyperthermia.
- Moller, M.G. et al. (2007). New ways of practicing surgery: alternatives and challenges. Bulletin of the American College of Surgeons.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
